Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis
Science Immunology · 2025
DOI: 10.1126/sciimmunol.adk7429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2025. Verfasst von Weili Xu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Hauptthemen laut MEDLINE: Crohn Disease, Ileitis, Intraepithelial Lymphocytes, Receptors, Antigen, T-Cell, gamma-delta. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Intraepithelial lymphocytes expressing the γδ T cell receptor (γδ IELs) provide immunosurveillance of the intestinal barrier but are reduced in patients with active Crohn’s disease (CD). Here, we report an underappreciated role for γδ IELs in maintaining immunological tolerance during the onset and progression of CD-like ileitis using TNF ΔARE/+ mice. We found that TNF-induced down-regulation of epithelial hepatocyte nuclear factor 4-gamma/butyrophilin is followed by a loss of ileal Vγ7 IELs and impaired barrier surveillance before the histological onset of disease. A reduction of immunoregulatory CD39 + γδ IELs coincided with the influx of immature, peripheral CD39 neg γδ T cells into the epithelium, leading to an expansion of induced IELs, whereas an earlier depletion of γδ IELs correlated with accelerated onset of ileal inflammation. Our findings identify multiple layers of γδ IEL dysregulation before ileitis development, indicating that the loss of steady-state immunoregulatory γδ IELs may contribute to the initiation of ileal CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
- Department of Pathology, Molecular and Cell-Based Medicine and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Genetics, Human Genetics Institute of New Jersey, Rutgers, the State University of New Jersey, Piscataway, NJ, USA.
- Cancer Institute of New Jersey, Rutgers, the State University of New Jersey, New Brunswick, NJ, USA.
- Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
- Departments of Pediatrics and Biochemistry and Molecular Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
ORCID-Profile: Weili Xu, Natasha B Golovchenko, Edie B Bucar, Jonathan J Hsieh, Kaylynn J Vidmar, Lanjing Zhang, Alexandros D Polydorides, Immo Prinz, George Kollias, Mark R Frey, Theresa T Pizarro, Michael P Verzi, Karen L Edelblum
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- NCRR NIH HHS
Zitieren
APA
Xu, W., Golovchenko, N. B., Martínez-Vargas, I. U., Fong, A., Rout, P., Achi, S., Bucar, E. B., Hsieh, J. J., Vidmar, K. J., Zhang, L., Polydorides, A. D., Prinz, I., Kollias, G., Frey, M. R., Pizarro, T. T., Verzi, M. P., & Edelblum, K. L. (2025). Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis. Science Immunology. https://doi.org/10.1126/sciimmunol.adk7429
Vancouver
Xu W, Golovchenko NB, Martínez-Vargas IU, Fong A, Rout P, Achi S, et al. Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis. Science Immunology. 2025. doi:10.1126/sciimmunol.adk7429
BibTeX
@article{Xu2025,
author = {Xu, Weili and Golovchenko, Natasha B and Martínez-Vargas, Irving U and Fong, Andrew and Rout, Prateeksha and Achi, Sajan and Bucar, Edie B and Hsieh, Jonathan J and Vidmar, Kaylynn J and Zhang, Lanjing and Polydorides, Alexandros D and Prinz, Immo and Kollias, George and Frey, Mark R and Pizarro, Theresa T and Verzi, Michael P and Edelblum, Karen L},
title = {Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis},
journal = {Science Immunology},
year = {2025},
doi = {10.1126/sciimmunol.adk7429}
}
EUVIMED